Can a website curb overprescribing of addictive anxiety pills?
NCT ID NCT07379073
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving doctors access to a special website can help them follow guidelines for prescribing benzodiazepines (medicines for anxiety and sleep). About 100 general practitioners in France will either get the website or continue as usual. Researchers will check prescription records to see if the website leads to shorter, safer treatment durations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Training intervention with access to a clinical support website (PsychoMG)
What this could lead to
If successful, this could give doctors a simple online tool to reduce risky long-term benzodiazepine use.
What could go wrong
This is a small, early-stage study in one French region. The website may not change prescribing habits, or results may not apply elsewhere.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENZODIAZEPINE USE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.